ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 59 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $38,946 | +111.8% | 5,263 | +124.1% | 0.00% | – |
| Q1 2024 | $18,385 | +72.5% | 2,348 | +11.9% | 0.00% | – |
| Q4 2023 | $10,658 | -24.4% | 2,098 | -11.9% | 0.00% | – |
| Q3 2023 | $14,101 | +94.1% | 2,382 | +143.3% | 0.00% | – |
| Q2 2023 | $7,264 | +242033.3% | 979 | +191.4% | 0.00% | – |
| Q1 2023 | $3 | -40.0% | 336 | -22.9% | 0.00% | – |
| Q4 2022 | $5 | -100.0% | 436 | -90.4% | 0.00% | -100.0% |
| Q3 2022 | $33,000 | +17.9% | 4,565 | -21.4% | 0.00% | 0.0% |
| Q2 2022 | $28,000 | +366.7% | 5,806 | +461.0% | 0.00% | – |
| Q1 2022 | $6,000 | +20.0% | 1,035 | +14.7% | 0.00% | – |
| Q4 2021 | $5,000 | +150.0% | 902 | +351.0% | 0.00% | – |
| Q3 2021 | $2,000 | -93.3% | 200 | -94.7% | 0.00% | -100.0% |
| Q2 2021 | $30,000 | +100.0% | 3,808 | +99.3% | 0.00% | – |
| Q1 2021 | $15,000 | +7.1% | 1,911 | +29.0% | 0.00% | – |
| Q3 2020 | $14,000 | – | 1,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 793,170 | $7,686,000 | 0.94% |
| Sio Capital Management, LLC | 189,062 | $1,832,000 | 0.36% |
| J. Goldman & Co LP | 168,749 | $1,635,000 | 0.11% |
| Rubric Capital Management LP | 57,518 | $557,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 13,823 | $134,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 66,899 | $648,000 | 0.02% |
| PDT Partners, LLC | 11,539 | $112,000 | 0.01% |
| Global Financial Private Client, LLC | 266 | $2,484 | 0.00% |
| Hartford Financial Management Inc. | 598 | $6,000 | 0.00% |
| FIRST TRUST ADVISORS LP | 34,353 | $333,000 | 0.00% |